Skip to Content
Merck

A0189

Amyloid β Protein Fragment 1-38

≥95% (HPLC), powder

Sign In to View Organizational & Contract Pricing.

Select a Size

Pricing and availability is not currently available.

About This Item

Empirical Formula (Hill Notation):
C184H277N51O56S
CAS Number:
Molecular Weight:
4131.54
UNSPSC Code:
12352202
NACRES:
NA.77
MDL number:

Skip To

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Amyloid β Protein Fragment 1-38, ≥95% (HPLC), powder

assay

≥95% (HPLC)

form

powder

color

white

solubility

H2O: 1 mg/mL

UniProt accession no.

storage temp.

−20°C

Quality Level

Gene Information

human ... APP(351)

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
A4848A1472A7973
form

powder

form

lyophilized powder

form

powder

form

lyophilized powder

assay

≥95% (HPLC)

assay

≥87% (HPLC)

assay

≥90% (HPLC)

assay

≥80% (HPLC)

Quality Level

200

Quality Level

200

Quality Level

100

Quality Level

200

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

solubility

H2O: 1 mg/mL

solubility

H2O: soluble

solubility

-

solubility

H2O: soluble

color

white

color

-

color

-

color

-

Biochem/physiol Actions

β-Amyloid peptide that forms cross-β-sheet fibrils of 70-90 Å diameter with similar antigenicity as those found in Alzheimer′s disease.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

P E Fraser et al.
Journal of neuroscience research, 28(4), 474-485 (1991-04-01)
To elucidate the relationship between amyloid fibril formation in Alzheimer disease (AD) and the primary structure of the beta-amyloid protein (beta-AP), we investigated the ability of peptides sharing sequences with beta-AP to form fibrils in vitro and to recognize anti-beta-amyloid
M P Mattson et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 12(2), 376-389 (1992-02-01)
In Alzheimer's disease (AD), abnormal accumulations of beta-amyloid are present in the brain and degenerating neurons exhibit cytoskeletal aberrations (neurofibrillary tangles). Roles for beta-amyloid in the neuronal degeneration of AD have been suggested based on recent data obtained in rodent
P E Gottschall
Neuroreport, 7(18), 3077-3080 (1996-11-25)
Since administration of anti-inflammatory drugs has been reported to possibly slow the progression of Alzheimer's disease, an effort was made to define effector functions induced by beta-amyloid (A beta) which may be inhibited by these drugs. Rat microglia in culture

Questions

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service